Literature DB >> 8500889

Facilitation of complement-dependent killing of the Lyme disease spirochete, Borrelia burgdorferi, by specific immunoglobulin G Fab antibody fragments.

S K Kochi1, R C Johnson, A P Dalmasso.   

Abstract

In the absence of specific antibody, Borrelia burgdorferi is resistant to the bactericidal action of complement, despite the capacity of the spirochete to activate complement. Complement-mediated killing of B. burgdorferi requires the presence of antiborrelial immunoglobulin G (IgG). The effect of bactericidal IgG takes place after formation of the C5 convertase. Therefore, we examined the ability of Fab fragments from bactericidal IgG to mediate killing of B. burgdorferi by complement. The complement-activating domain of IgG, the Fc fragment, was not required for killing of borreliae, as monovalent Fab fragments prepared from immune IgG were also able to mediate killing. However, the killing efficiency of the Fab fragments was less than that of intact IgG, suggesting that the bactericidal activity of IgG is enhanced by divalency. IgG Fab-mediated killing occurred without increased complement activation or C3 fluid-phase consumption. Cell killing proceeded via the classical complement pathway, as no killing of Fab fragment-sensitized cells was observed in human serum deficient in C2. These results demonstrate directly that the bactericidal effect of anti-B. burgdorferi IgG is independent of the complement-activating properties of the antibody.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500889      PMCID: PMC280880          DOI: 10.1128/iai.61.6.2532-2536.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody.

Authors:  A G Barbour; S L Tessier; W J Todd
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

2.  Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae.

Authors:  K A Joiner; K A Warren; E J Brown; J Swanson; M M Frank
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

3.  Separate pathways of C activation by measles virus cytotoxic antibodies: subclass analysis and capacity of F(ab) molecules to activate C via the alternative pathway.

Authors:  A Ehrnst
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

4.  The spirochetal etiology of Lyme disease.

Authors:  A C Steere; R L Grodzicki; A N Kornblatt; J E Craft; A G Barbour; W Burgdorfer; G P Schmid; E Johnson; S E Malawista
Journal:  N Engl J Med       Date:  1983-03-31       Impact factor: 91.245

5.  Alternative complement pathway-mediated lysis of measles virus infected cells: induction by IgG antibody bound to individual viral glycoproteins and comparative efficacy of F(ab')2 and Fab' fragments.

Authors:  J G Sissons; N R Cooper; M B Oldstone
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

6.  Transformation of trypomastigote forms of Trypanosoma cruzi into activators of alternative complement pathway by immune IgG fragments.

Authors:  T L Kipnis; A U Krettli; W Dias da Silva
Journal:  Scand J Immunol       Date:  1985-08       Impact factor: 3.487

7.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

8.  Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness.

Authors:  J E Craft; D K Fischer; G T Shimamoto; A C Steere
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

9.  Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.

Authors:  K A Joiner; R C Goldman; C H Hammer; L Leive; M M Frank
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

10.  IgG bearing covalently bound C3b has enhanced bactericidal activity for Escherichia coli 0111.

Authors:  K A Joiner; L F Fries; M A Schmetz; M M Frank
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

View more
  14 in total

Review 1.  Host-pathogen interactions in the immunopathogenesis of Lyme disease.

Authors:  L T Hu; M S Klempner
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

2.  Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi.

Authors:  J Ma; C Gingrich-Baker; P M Franchi; P Bulger; R T Coughlin
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

3.  Killing of Borrelia burgdorferi by antibody elicited by OspA vaccine is inefficient in the absence of complement.

Authors:  J M Nowling; M T Philipp
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Cryptic and exposed invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi sl.

Authors:  F T Liang; J M Nowling; M T Philipp
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

5.  Borrelia burgdorferi escape mutants that survive in the presence of antiserum to the OspA vaccine are killed when complement is also present.

Authors:  M Solé; C Bantar; K Indest; Y Gu; R Ramamoorthy; R Coughlin; M T Philipp
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

6.  Interactions of OspA monoclonal antibody C3.78 with Borrelia burgdorferi within ticks.

Authors:  Clay L Gipson; Aravinda M de Silva
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

7.  New Zealand White Rabbits Effectively Clear Borrelia burgdorferi B31 despite the Bacterium's Functional vlsE Antigenic Variation System.

Authors:  Maliha Batool; Andrew E Hillhouse; Yurij Ionov; Kelli J Kochan; Fatemeh Mohebbi; George Stoica; David W Threadgill; Alex Zelikovsky; Suryakant D Waghela; Dominique J Wiener; Artem S Rogovskyy
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

8.  Ability of the borreliacidal antibody test to confirm lyme disease in clinical practice.

Authors:  Steven M Callister; Dean A Jobe; William A Agger; Ronald F Schell; Todd J Kowalski; Steven D Lovrich; Jennifer A Marks
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

9.  Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey.

Authors:  M K Aydintug; Y Gu; M T Philipp
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

10.  Single exposure of mice to Borrelia burgdorferi elicits immunoglobulin G antibodies characteristic of secondary immune response without production of interleukin-4 by immune T cells.

Authors:  A B Frey; T D Rao
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.